KHA Releases One-Pager Supporting SB 27

Share

Protect Private Money Providing Patient Access

The 340B drug discount program is a privately funded, federally administered system. The program allows non-profit, safety-net hospitals to purchase outpatient medications from pharmaceutical manufacturers at the same price the manufacturers charge their best customers – NOT for free.

Pharmaceutical manufacturers, which continue to have record profits, agreed to fund the 340B program in order to be a part of Obamacare. Now they want to back out of that commitment. Their refusal to ship prescription drugs comes at the expense of the poorest and most vulnerable patients being served by 340B hospitals.

The savings from the program help Kentucky hospitals to maintain access to care and make it possible for hospitals to offer additional services to their patients.

Latest News

News
September 12, 2025
The Kentucky Trustee is a quarterly newsletter KHA produces for hospital boards.
News
September 10, 2025
KHA Senior Vice President of Policy and Government Relations Jim Musser is traveling the state right now for multiple events and speaking engagements.
News Podcast
September 4, 2025
University of Louisville Professor of Pediatrics and practicing neonatologist with the Norton Children's Medical Group Dr. Lori Devlin joins the podcast.